RicercaInizia una nuova ricerca
NOTA: è possibile cercare una corrispondenza esatta usando i doppi apici, ad es: "evoluzione della specie". Qualora si cerchi un identificativo, è consigliabile cercarlo in due modi differenti: tra apici con caratteri speciali es: "978-94-6366-274" oppure senza caratteri speciali solo come sequenza numerica: es 978946366274.
Anti-TNF biosimilars in Crohn's Disease: a patient-centric interdisciplinary approach
2019-01-01 Peyrin-Biroulet, L; Danese, S; Cummings, F; Atreya, R; Greveson, K; Pieper, B; Kang, T
Anti-TNF Biosimilars in Inflammatory Bowel Disease: Searching the Proper Patient's Profile
2019-01-01 Danese, S; Fiorino, G
Antibodies to infliximab in patients treated with either the reference biologic or the biosimilar CT-P13 show identical reactivity towards biosimilars CT-P13 and SB2 in inflammatory bowel disease
2017-01-01 Fiorino, G; Ruiz-Aguello, Mb; Maguregui, A; Nagore, D; Radice, S; Gilardi, D; Correale, C; Allocca, M; Furfaro, F; Alfieri, M; Martinez, A; Danese, S
Antibodies to Saccharomyces cerevisiae: Are they useful in clinical practice?
2003-01-01 Candelli, M; Papa, A; Nista, Ec; Danese, S; Armuzzi, A; Bartolozzi, F; Tondi, P; Ojetti, V; Gasbarrini, G; Gasbarrini, A
Antibody to alpha(4)beta(7) integrin for ulcerative colitis
2005-01-01 Danese, S; De La Rue, Sa; Gasbarrini, A
Antigenic response to CT-P13 and infliximab originator in inflammatory bowel disease patients shows similar epitope recognition
2018-01-01 Goncalves, J; Santos, M; Acurcio, R; Iria, I; Gouveia, L; Brito, Pm; Cunha-Santos, Ac; Barbas, A; Galvao, J; Barbosa, I; da Silva, Fa; Alcobia, A; Cavaco, M; Cardoso, M; Alves, Jd; Carey, Jj; Dorner, T; Fonseca, Je; Palmela, C; Torres, J; Vieira, Cl; Trabuco, D; Fiorino, G; Strik, A; Yavzori, M; Rosa, I; Correia, L; Magro, F; D'Haens, G; Ben-Horin, S; Lakatos, Pl; Danese, S
Antigenic response to CT-P13 and remicade in inflammatory bowel disease patients shows similar epitope recognition
2018-01-01 Goncalves, J; Santos, M; Acurcio, R; Iria, I; Gouveia, L; Brito, P; Santos, Acc; Barbas, A; Galvao, J; Barbosa, I; da Silva, Fa; Alcobia, A; Cavaco, M; Cardoso, M; Alves, Jd; Carey, J; Dorner, T; Fonseca, Je; Palmela, C; Torres, J; Vieira, Cl; Trabuco, D; Fiorino, G; Strik, A; Yavzori, M; Rosa, I; Correia, L; Magro, F; D'Haens, G; Ben-Horin, S; Lakatos, P; Danese, S
Aortic Stiffening Is an Extraintestinal Manifestation of Inflammatory Bowel Disease: Review of the Literature and Expert Panel Statement
2020-01-01 Zanoli, Luca; Mikhailidis, Dimitri P; Bruno, Rosa Maria; Abreu, Maria T; Danese, Silvio; Eliakim, Rami; Gionchetti, Paolo; Katsanos, Konstantinos H; Kirchgesner, Julien; Koutroubakis, Ioannis E; Kucharzik, Torsten; Lakatos, Peter L; Nguyen, Geoffrey C; Papa, Alfredo; Vavricka, Stephan R; Wilkinson, Ian B; Boutouyrie, Pierre
Application of Artificial Intelligence to Gastroenterology and Hepatology
2020-01-01 Le Berre, C; Sandborn, Wj; Aridhi, S; Devignes, Md; Fournier, L; Smail-Tabbone, M; Danese, S; Peyrin-Biroulet, L
Approaches to Integrating Biomarkers Into Clinical Trials and Care Pathways as Targets for the Treatment of Inflammatory Bowel Diseases
2019-01-01 Dulai, Ps; Peyrin-Biroulet, L; Danese, S; Sands, Be; Dignass, A; Turner, D; Mantzaris, G; Scholmerich, J; Mary, Jy; Reinisch, W; Sandborn, Wj
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Anti-TNF biosimilars in Crohn's Disease: a patient-centric interdisciplinary approach | 1-gen-2019 | Peyrin-Biroulet, L; Danese, S; Cummings, F; Atreya, R; Greveson, K; Pieper, B; Kang, T | |
| Anti-TNF Biosimilars in Inflammatory Bowel Disease: Searching the Proper Patient's Profile | 1-gen-2019 | Danese, S; Fiorino, G | |
| Antibodies to infliximab in patients treated with either the reference biologic or the biosimilar CT-P13 show identical reactivity towards biosimilars CT-P13 and SB2 in inflammatory bowel disease | 1-gen-2017 | Fiorino, G; Ruiz-Aguello, Mb; Maguregui, A; Nagore, D; Radice, S; Gilardi, D; Correale, C; Allocca, M; Furfaro, F; Alfieri, M; Martinez, A; Danese, S | |
| Antibodies to Saccharomyces cerevisiae: Are they useful in clinical practice? | 1-gen-2003 | Candelli, M; Papa, A; Nista, Ec; Danese, S; Armuzzi, A; Bartolozzi, F; Tondi, P; Ojetti, V; Gasbarrini, G; Gasbarrini, A | |
| Antibody to alpha(4)beta(7) integrin for ulcerative colitis | 1-gen-2005 | Danese, S; De La Rue, Sa; Gasbarrini, A | |
| Antigenic response to CT-P13 and infliximab originator in inflammatory bowel disease patients shows similar epitope recognition | 1-gen-2018 | Goncalves, J; Santos, M; Acurcio, R; Iria, I; Gouveia, L; Brito, Pm; Cunha-Santos, Ac; Barbas, A; Galvao, J; Barbosa, I; da Silva, Fa; Alcobia, A; Cavaco, M; Cardoso, M; Alves, Jd; Carey, Jj; Dorner, T; Fonseca, Je; Palmela, C; Torres, J; Vieira, Cl; Trabuco, D; Fiorino, G; Strik, A; Yavzori, M; Rosa, I; Correia, L; Magro, F; D'Haens, G; Ben-Horin, S; Lakatos, Pl; Danese, S | |
| Antigenic response to CT-P13 and remicade in inflammatory bowel disease patients shows similar epitope recognition | 1-gen-2018 | Goncalves, J; Santos, M; Acurcio, R; Iria, I; Gouveia, L; Brito, P; Santos, Acc; Barbas, A; Galvao, J; Barbosa, I; da Silva, Fa; Alcobia, A; Cavaco, M; Cardoso, M; Alves, Jd; Carey, J; Dorner, T; Fonseca, Je; Palmela, C; Torres, J; Vieira, Cl; Trabuco, D; Fiorino, G; Strik, A; Yavzori, M; Rosa, I; Correia, L; Magro, F; D'Haens, G; Ben-Horin, S; Lakatos, P; Danese, S | |
| Aortic Stiffening Is an Extraintestinal Manifestation of Inflammatory Bowel Disease: Review of the Literature and Expert Panel Statement | 1-gen-2020 | Zanoli, Luca; Mikhailidis, Dimitri P; Bruno, Rosa Maria; Abreu, Maria T; Danese, Silvio; Eliakim, Rami; Gionchetti, Paolo; Katsanos, Konstantinos H; Kirchgesner, Julien; Koutroubakis, Ioannis E; Kucharzik, Torsten; Lakatos, Peter L; Nguyen, Geoffrey C; Papa, Alfredo; Vavricka, Stephan R; Wilkinson, Ian B; Boutouyrie, Pierre | |
| Application of Artificial Intelligence to Gastroenterology and Hepatology | 1-gen-2020 | Le Berre, C; Sandborn, Wj; Aridhi, S; Devignes, Md; Fournier, L; Smail-Tabbone, M; Danese, S; Peyrin-Biroulet, L | |
| Approaches to Integrating Biomarkers Into Clinical Trials and Care Pathways as Targets for the Treatment of Inflammatory Bowel Diseases | 1-gen-2019 | Dulai, Ps; Peyrin-Biroulet, L; Danese, S; Sands, Be; Dignass, A; Turner, D; Mantzaris, G; Scholmerich, J; Mary, Jy; Reinisch, W; Sandborn, Wj |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Opzioni
Scopri
Tipologia
- 1 Contributo su Rivista 718
- 1 Contributo su Rivista::1.1 Arti... 674
- 1 Contributo su Rivista::1.5 Abst... 42
- 1 Contributo su Rivista::1.2 Rece... 1
- 1 Contributo su Rivista::1.8 Mate... 1
Data di pubblicazione
- 2020 - 2024 157
- 2010 - 2019 434
- 2000 - 2009 119
- 1994 - 1999 8
Rivista
- JOURNAL OF CROHN'S AND COLITIS 81
- GASTROENTEROLOGY 72
- GUT 52
- ALIMENTARY PHARMACOLOGY & THERAPE... 44
- DIGESTIVE AND LIVER DISEASE 30
- INFLAMMATORY BOWEL DISEASES 30
- CURRENT DRUG TARGETS 26
- CLINICAL GASTROENTEROLOGY AND HEP... 25
- NATURE REVIEWS. GASTROENTEROLOGY ... 17
- UNITED EUROPEAN GASTROENTEROLOGY ... 16
Keyword
- Humans 43
- inflammatory bowel disease 29
- ulcerative colitis 23
- Crohn’s disease 20
- Crohn's disease 19
- COVID-19 18
- Inflammatory Bowel Diseases 18
- SARS-CoV-2 18
- Pandemics 16
- Coronavirus Infections 15
Lingua
- eng 229
- und 3
Accesso al fulltext
- no fulltext 630
- reserved 80
- open 8